Scitara
PrivateLast Round
Seed Round
Jun 18, 2026
Total Funding Raised
$35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Scitara is a SaaS and HealthTech company that provides a laboratory-specific, cloud-based software platform designed to offer a standardized platform for communication and automated workflows.
Sector
Healthcare & Life Sciences
Verticals
Data Integration, Workflow Automation, Vertical SaaS, Platform-as-a-Service, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scitara Comparables
Compare Scitara with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ganymede Bio | 86% | |
| TetraScience | 84% | |
| UniteLabs | 84% | |
Scitara Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 18, 2026 | ||||
| Series B Extension | Oct 23, 2023 | ||||
| Series B | Jan 11, 2022 | ||||
| Series A | Jan 27, 2021 |
Key People
Founding team and executive leadership
Scitara Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flybridge | Series A, Series B |
| Northpond Ventures | Series B Extension, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 45, representing 49% of headcount.
- Jun 21, 2026
Monthly visitors grew 300% MoM, reaching 9.4K.
Scitara Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Scitara's valuation, stock price, and market status.